APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis

dc.creatorUddin M.S.
dc.creatorKabir M.T.
dc.creatorAl Mamun A.
dc.creatorAbdel-Daim M.M.
dc.creatorBarreto G.E.
dc.creatorAshraf G.M.
dc.date.accessioned2020-09-02T22:29:28Z
dc.date.accessioned2022-11-08T20:20:47Z
dc.date.available2020-09-02T22:29:28Z
dc.date.available2022-11-08T20:20:47Z
dc.date.created2020-09-02T22:29:28Z
dc.date.issued2019
dc.identifier56, 4, 2450-2465
dc.identifier08937648
dc.identifierhttps://hdl.handle.net/20.500.12728/6461
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143744
dc.languageen
dc.publisherHumana Press Inc.
dc.subjectAlzheimer’s disease
dc.subjectAmyloid β
dc.subjectAPOE4
dc.subjectNeurofibrillary tangles
dc.subjectSenile plaques
dc.subjectTauopathy
dc.subjectABC transporter A1
dc.subjectalpha synuclein
dc.subjectamyloid beta protein
dc.subjectamyloid precursor protein
dc.subjectapolipoprotein E
dc.subjectapolipoprotein E4
dc.subjectfluindostatin
dc.subjectlow density lipoprotein receptor related protein
dc.subjectmonoclonal antibody
dc.subjectn (2,2,2 trifluoroethyl) n [4 (2,2,2 trifluoro 1 hydroxy 1 trifluoromethylethyl)phenyl]benzenesulfonamide
dc.subjectpresenilin 1
dc.subjectpresenilin 2
dc.subjectretinoid X receptor
dc.subjecttau protein
dc.subjectamyloid
dc.subjectapolipoprotein E
dc.subjectapolipoprotein E4
dc.subjectAlzheimer disease
dc.subjectamyloid plaque
dc.subjectamyloidosis
dc.subjectcognitive defect
dc.subjectfrontotemporal dementia
dc.subjectgenetic risk
dc.subjecthippocampus
dc.subjecthomozygote
dc.subjecthuman
dc.subjectlipid metabolism
dc.subjectnerve cell plasticity
dc.subjectnerve degeneration
dc.subjectnervous system inflammation
dc.subjectnonhuman
dc.subjectpathogenesis
dc.subjectprotein aggregation
dc.subjectReview
dc.subjectsenile plaque
dc.subjectsynucleinopathy
dc.subjectAlzheimer disease
dc.subjectanimal
dc.subjectgenetic predisposition
dc.subjectgenetics
dc.subjectmetabolism
dc.subjectpathology
dc.subjectrisk factor
dc.subjectAlzheimer Disease
dc.subjectAmyloid
dc.subjectAnimals
dc.subjectApolipoprotein E4
dc.subjectApolipoproteins E
dc.subjectGenetic Predisposition to Disease
dc.subjectHumans
dc.subjectRisk Factors
dc.titleAPOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
dc.typeReview


Este ítem pertenece a la siguiente institución